FOP Australia support ground breaking international FOP research through the IFOPA Competitive Research Grant program. We are very proud to sponsor a new project by Associate Professor Ed Hsiao at University of San Francisco, and Professor Pamela Yelick at Tuffs University looking at ‘Interrogating new therapeutic targets for human FOP’ . This project will not only look investigate new treatments, but in doing so will also develop a new zebra fish FOP model which will be a helpful tool for future in vivo FOP research.
Many FOP Australia supporters will know of A/Prof Hsiao’s clinical and research FOP work, including his role as a primary investigator in clinical trials. In the spirit of collaboration so crucial for rare disease research, he formed a partnership with Prof Yelick following the 2016 Drug Development Forum, both recognising the potential for new in vivo models to test potential FOP treatments.
A/Prof Hsiao and Prof Yelick’s collaboration was one of four CRG winners announced from a highly competitive field at the IFOPA Drug Development Forum on the 14th October. The CRG program is designed to accelerate progress towards transformative FOP therapies, with applications from researchers all over the world reviewed by an expert independent scientific advisory board. Supporting this process enables FOP Australia to make sure that your donations are used for maximum effect in the fight to #cureFOP.
Thank you for your ongoing support of FOP Australia and crucial work by researchers such as A/Prof Hsiao and Prof Yelick. We look forward to keeping you informed of their progress.
FOP Australia chairperson Dr Lydia Scott congratulates A/Prof Ed Hsiao of UCSF and Prof Pam Yelick from Tuffs University, 2017 IFOPA Competitive Research Grant recipients
Title photo: FOP Australia chairperson Lydia Scott and FOP Friends (UK) chairperson Chris Bedford-Gay congratulate the 2017 IFOPA Competitive Research Grant recipients: Pam Yelick, Ed Hsiao, Yuji Mishina, Ben Levi, Daniel Perrien, and Jay Groppe
